D-dimer, plasminogen activator inhibitor-1, prothrombin fragments and protein C - Role in prothrombotic state of colorectal cancer

Neoplasma

Volumn 58, Issue 3, 2011, Pages 235-238

  Mytnik, M ^a   Stasko, J ^b  

^a Faculty Hospital J A Reimans   (Slovakia)

^b Martinska Fakultna Nemocnica   (Slovakia)

Author keywords

Colorectal cancer; D dimers; Hypercoagulation; Plasminogen activator inhibitor; Protein C

Indexed keywords

D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTHROMBIN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; PEPTIDE FRAGMENT; PROTEIN PRECURSOR; PROTHROMBIN FRAGMENT 1; PROTHROMBIN FRAGMENT 2;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CANCER GROWTH; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; THROMBOSIS; BLOOD; COLORECTAL TUMOR; MIDDLE AGED;

AGED; COLORECTAL NEOPLASMS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN PRECURSORS; PROTHROMBIN; THROMBOSIS;

EID: 79961111916     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_03_235     Document Type: Article

References (11)

1. AY C, VORMITTAG R, DUNKLER D, SIMANEK R. D-Dimer and Prothrombin Fragment 1+2 Predict Venous Thromboembolism in Patients With Cancer. Journal of Clinical Oncology 2009; 25: 4124-4129 doi:10.1200/JCO.2008.21.7752
2. BAKER EA, BERGIN FG, LEAPER DJ. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression. J Clin Pathol 2000; 53: 307-312 misctextdoi:10.1136/mp.53.6.307/misctext
3. BLACKWELL K, HAROON Z, BROADWATER G. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol 2000; 30: 600-608
4. DARMOUL D, GRATIO V, DEVAUD H. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Pathol 2003; 162: 1503-1513
5. KILIC M, YOLDAS O, KESKEK M. Prognostic value of plasma D-dimer levels in patients with colorectal cancer. Colorectal Dis 2008; 10: 238-241. doi:10.1111/j.1463-1318.2007.01374.x
6. MOCHIZUKI S, YOSHINO T, KOJIMA T. Therapeutic significance of a D-dimer in colorectal cancer patients treated with standard chemotherapy plus Bevacizumab. Jpn J Clin Oncol 2010; 40: 933-937. doi:10.1093/jjco/hyq058
7. OYA M, AKIAMA Z, OKUYAMA T. High preoperative D dimer level is associated with advanced tumor stage in patients with colorectal cancer. Jpn J Clin Onkol 2001; 31: 388-394. misctextdoi:10.1093/jjco/hye075/misctext
8. SALGADO R, WEYTIENS R, BENOY I, VERMEULEN P. Concentrations of angiogenic and hemostatic factors originating from primary colorectal carcinomas. A quantitative analysis. Ann Oncol 2000; 11: 10-14. doi:10.1023/A:1008331410359
9. STENDER M., MOGENS T, LARSEN T. Preoperative plasma D-dimer is a predictor of postoperative deep venous thrombosis in colorectal cancer patients. Dis colon rectum 2009; 52: 446-451
10. STEPHENS R, NIELSEN H, CHRISTENSEN I. Plasma urokinase receptor levels in patients with colorectal cancer. Journal of National Cancer Institute 1999; 91: 869-874. doi:10.1093/ jnci/91.10.869
11. XU G, ZHANG Y, HUANG W. Relationship between plasma D-dimer levels and clinicopathologic parameters cancer patients. World J Gastroenterol 2004; 10: 922-923.